Home About EMBARC What is EMBARC? Steering Committee International Advisory Board Registry Transparency Notice EMBARC Members Acknowledgements NEWS Latest News Newsletters 2019 Newsletters 2018 Newsletters 2017 Newsletters 2016 Newsletters 2015 RESEARCH Active projects FRIENDS Publications Research Roadmap EDUCATION Assessment and causes Courses and Resources EMBARC Webinar series – ‘Lessons in Bronchiectasis’ Microbiology NTM-lung References Severity assessment Treatment What is Bronchiectasis? Patient Resource Registry Documents EMBARC Registry EMBARC Registry
Risk of Development of Resistance in Patients with Non-Cystic Fibrosis BronchiectasisTreated with Inhaled Antibiotics Regan KH, Hill AT Link to publication page: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096916 Journal Ref: Curr Pulmonol Rep. 2018;7(3):63-71. doi: 10.1007/s13665-018-0202-7. Epub 2018 Jul 5
